BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//pretalx//sciencenext.org//WF8JGX
BEGIN:VTIMEZONE
TZID:EET
BEGIN:STANDARD
DTSTART:20001029T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10;UNTIL=20061029T000000Z
TZNAME:EET
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
END:STANDARD
BEGIN:STANDARD
DTSTART:20071028T050000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10;UNTIL=20141026T020000Z
TZNAME:EET
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
END:STANDARD
BEGIN:STANDARD
DTSTART:20151108T050000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=11;UNTIL=20151108T020000Z
TZNAME:EET
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
END:STANDARD
BEGIN:STANDARD
DTSTART:20160907T010000
RRULE:FREQ=YEARLY;BYDAY=1WE;BYMONTH=9
TZNAME:+03
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20000326T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20060326T000000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20070325T040000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20100328T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20110328T040000
RRULE:FREQ=YEARLY;BYDAY=4MO;BYMONTH=3;UNTIL=20110328T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20120325T040000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20130331T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20140331T040000
RRULE:FREQ=YEARLY;BYDAY=5MO;BYMONTH=3;UNTIL=20140331T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20150329T040000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20160327T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:pretalx-ifos2026-WF8JGX@sciencenext.org
DTSTART;TZID=EET:20260913T093000
DTEND;TZID=EET:20260913T100000
DESCRIPTION:<p style="margin-left: 0px!important\;">The injection of Platel
 et-Rich Plasma (PRP) in the olfactory cleft is a promising approach in the
  management of patients with a long-lasting post-viral olfactory dysfuncti
 on. To date\, several controlled studies supported its superiority over ol
 factory training but many grey areas persist\, particularly the physiologi
 cal mechanisms underlying the functioning of PRP\, indications where PRP c
 ould have a benefit on recovery\, and the required&nbsp\;number of injecti
 ons for having the maximum effect of PRP and duration interval between inj
 ections.&nbsp\;In this session\, three experienced practitioners will disc
 uss about the usefulness\, protocol and perspectives of PRP injections.&nb
 sp\;</p>
DTSTAMP:20260618T235022Z
LOCATION:Phoniatrics 4 + Swallowing
SUMMARY:Platelet-Rich Plasma Injections into the Olfactory Clefts of Patien
 ts with Olfactory Dysfunction: An Updated Clinical Practice - Jerome LECHI
 EN\, Zara Patel
URL:https://sciencenext.org/ifos2026/talk/WF8JGX/
END:VEVENT
END:VCALENDAR